(NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

Successful product launches rely on more than just scientific excellence or commercial savvy—they demand seamless collaboration between medical and commercial teams. These functions, while distinct, ...

Microbot Medical is expanding its team ahead of the anticipated U.S. launch of the LIBERTY Endovascular Robotic System in Q3 2025. Microbot Medical Inc. announced the expansion of its commercial team ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Having just fallen onto pavement from the top step of a tall ladder to bust up my right hand, I feel moved to write about the medical arts. There are some pretty complicated medical commercials making ...